Clotrimazole Lozenge

Major

Clotrimazole Lozenge Alfentanil Increased ALfentanil exposure and an increased risk of respiratory depression Details Clotrimazole Lozenge Bedaquiline Sirturo Increased bedaquiline exposure Details Clotrimazole Lozenge Colchicine Colcrys Increased colchicine exposure and an increased risk of colchicine-related toxicity Details Clotrimazole Lozenge Dihydroergotamine Brekiya Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lozenge Doxorubicin Adriamycin Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Clotrimazole Lozenge Doxorubicin Hydrochloride Liposome Increased doxorubicin exposure and an increased risk of doxorubicin-related adverse reactions Details Clotrimazole Lozenge Ergoloid Mesylates Alkergot® Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lozenge Ergonovine Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lozenge Ergotamine Ergomar Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lozenge Finerenone Kerendia Increased finerenone exposure and an increased risk of finerenone-related adverse effects Details Clotrimazole Lozenge Haloperidol Increased haloperidol exposure and an increased risk of haloperidol-related adverse events, including QTc interval prolongation Details Clotrimazole Lozenge Lemborexant Dayvigo Increased lemborexant exposure and an increased risk of lemborexant-related adverse reactions. Details Clotrimazole Lozenge Lisuride Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lozenge Lomitapide Increased lomitapide exposure Details Clotrimazole Lozenge Loperamide Diamode Increased loperamide exposure and an increased risk of loperamide-related adverse reactions Details Clotrimazole Lozenge Meperidine Demerol Increased meperidine exposure and risk of increased or prolonged opioid effects Details Clotrimazole Lozenge Metergoline Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lozenge Methylergonovine Methergine Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lozenge Methysergide Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lozenge Mifepristone Korlym Increased miFEPRIStone exposure Details Clotrimazole Lozenge Nicergoline Increased ergot derivatives exposure and an increased risk of ergotism (nausea, vomiting, vasospastic ischemia) Details Clotrimazole Lozenge Nifedipine Adalat® Increased NIFEdipine exposure Details Clotrimazole Lozenge Paclitaxel Abraxane Increased PACLitaxel exposure Details Clotrimazole Lozenge Paclitaxel Protein-Bound Increased PACLitaxel exposure Details Clotrimazole Lozenge Pimozide Increased pimozide exposure Details Clotrimazole Lozenge Roflumilast Daliresp Increased roflumilast exposure and an increased risk of roflumilast-related adverse events Details Clotrimazole Lozenge Tacrolimus Astagraf Increased tacrolimus concentration and an increased risk of toxicity Details Clotrimazole Lozenge Tramadol ConZip Increased traMADol exposure and an increased risk of seizures, serotonin syndrome and opioid toxicity Details Clotrimazole Lozenge Voriconazole Vfend Increased voriconazole exposure and an increased risk of voriconazole-related adverse reaction Details

Moderate

Clotrimazole Lozenge Artemether Increased artemether/lumefantrine exposure and an increased risk of potentiated QT prolongation Details Clotrimazole Lozenge Dofetilide Tikosyn Increased dofetilide exposure Details Clotrimazole Lozenge Hydrocortisone Ala-Cort Increased hydrocortisone exposure and an increased risk of hydrocortisone-related adverse reactions Details Clotrimazole Lozenge Lumefantrine Increased artemether/lumefantrine exposure and an increased risk of potentiated QT prolongation Details Clotrimazole Lozenge Sirolimus Felycin An increased risk of sirolimus toxicity (anemia, leukopenia, thrombocytopenia, hypokalemia, fever, diarrhea) Details Clotrimazole Lozenge Trimetrexate Increased trimetrexate toxicity (bone marrow suppression, renal and hepatic dysfunction, and gastrointestinal ulceration) Details